
51 - 200 employees
Founded 2020
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $111.8M Series A - Syncromune on 2024-12
Biotechnology • Pharmaceuticals • Healthcare
Syncromune is a clinical-stage company developing a novel intratumoral cancer immunotherapy platform called SYNC-T. The platform is designed to be delivered directly into target tumors to synchronize the immune system to recognize and destroy cancer throughout the body. Its lead investigational therapy, SV-102, is being evaluated in the LEGION-100 Phase 2 trial for metastatic castration-resistant prostate cancer. The company’s materials are directed at healthcare professionals and note that its compounds are investigational and not yet approved by regulatory authorities.
🕒 July 29
🗣️🇨🇳 Chinese Required
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2020
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $111.8M Series A - Syncromune on 2024-12
Biotechnology • Pharmaceuticals • Healthcare
Syncromune is a clinical-stage company developing a novel intratumoral cancer immunotherapy platform called SYNC-T. The platform is designed to be delivered directly into target tumors to synchronize the immune system to recognize and destroy cancer throughout the body. Its lead investigational therapy, SV-102, is being evaluated in the LEGION-100 Phase 2 trial for metastatic castration-resistant prostate cancer. The company’s materials are directed at healthcare professionals and note that its compounds are investigational and not yet approved by regulatory authorities.
• oversee the execution of the analytical strategy for drug substance and drug product development. • define and implement analytical development strategies to support CMC programs. • provide technical leadership in analytical sciences, including chromatography, spectroscopy, and characterization techniques. • guide analytical development activities at CDMO and CTL, including method development, optimization, transfer, validation, troubleshooting. • foster collaboration with cross-functional groups including Process Development, Quality, and Regulatory Affairs. • author and review analytical sections of regulatory submissions (IND, IMPD, NDA, BLA). • ensure adherence to GMP, ICH, and FDA guidelines for analytical activities. • drive continuous improvement and innovation in analytical technologies and processes.
• Ph.D. or M.S. degree in Analytical Chemistry, Pharmaceutical Sciences, Biochemistry, or a related field. • 8+ years of pharmaceutical or biotechnology industry experience specializing in analytical development. • working knowledge of cGMP, ICH, and regulatory guidelines. • hands-on experience managing global CTLs and CDMOs. • strong technical expertise in separation science, such as liquid chromatography or mass spectrometry. • strong technical experience in at least one of the modalities: monoclonal antibody and/ or oligonucleotide. • experience in method development, validation, and lifecycle management for QC methods. • good to have experience in complex drug products, such as co-formulation, multi-components, conjugates, etc. • good to have experience in extended characterization & comparability studies to support BLA submission. • good to have experience in authoring technical and scientific documents for regulatory submissions, including IND and BLA filings. • good to have late phase experience, such as PPQ and commercialization. • proficient in both English and Mandarin are highly encouraged to apply.
• cash incentive compensation • equity incentive compensation • employee benefits under the Company’s benefit plans
Apply Now🕒 July 29
Senior Director, Digital Strategy responsible for bridging data science and communications strategies in the Corporate Positioning & Insights practice. Working with clients to deliver actionable communication insights and support digital initiatives.
🕒 July 29
Senior Director overseeing technical direction of cloud and infrastructure platform architecture. Leading teams in developing and executing modern infrastructure strategies in a hybrid environment.
🕒 July 29
Promote Butler University as an Associate Director for International Admission. Assist prospective students and families with admission processes to increase international student enrollment.
🕒 July 29
Director/Senior Director of National Accounts for Stoke Therapeutics. Leading payer access strategy for rare and specialty products in biotechnology.
🇺🇸 United States – Remote
💵 $238k - $322k / year
💰 $125M Post-IPO Equity - Stoke Therapeutics on 2024-03
⏰ Full Time
🟠 Senior
👔 Director
🕒 July 29
Director/Senior Director managing national accounts for a biotech focused on RNA medicine. Leading payer access strategy and engagement for innovative therapies in rare diseases.
🇺🇸 United States – Remote
💵 $238k - $268k / year
💰 $125M Post-IPO Equity - Stoke Therapeutics on 2024-03
⏰ Full Time
🟠 Senior
👔 Director